The trajectory of companies tied to Sildenafil's past presents a complex investment scenario . While the initial boom generated substantial returns , generic copies have significantly eroded revenue. https://bookmark-search.com/story21500985/copyright-s-flagship-product-and-pharma-a-uncertain-opportunity